title: Does pancreaticosplenectomy contribute to better survival?
abstract: OBJECTIVE
  This study was conducted to clarify the impact of pancreaticosplenectomy on the prognosis of patients with gastric carcinoma.
  
  
  METHODS
  Two hundred and seventy-two patients who underwent total gastrectomy with distal pancreatectomy and splenectomy were retrospectively reviewed.
  
  
  RESULTS
  Lymph node metastases at the splenic hilum (#10) and along the splenic artery (#11) occurred in 12.4% and 19.2% of cases, respectively. The 5-year survival rate of those without metastasis at #10 was 62.8%. Once nodal metastasis occurred, the prognosis became very poor; only 18.2% in those with a single positive node and 15.4% of those with two or more positive nodes at this location survived 5 years. Similar trends in survival were observed with respect to nodes at #11. When stratified by nodal status as currently determined by microscopic examination, pancreaticosplenectomy saved 4.5% of patients with positive nodes, but was insufficient in 17.3% of cases and was not necessary in the 78.2% of cases who were node negative at these locations.
  
  
  CONCLUSIONS
  The data indicate that pancreaticosplenectomy can save some patients with positive nodes in these regions; however, the small survival benefit does not provide a basis for the general application of this highly morbid procedure. To further evaluate these results in a randomized study, selection of a subset of patients who are likely to have metastasis is the key.
authors.affiliation: Department of Surgery, Yokohama City Kowan Hospital, 3-2-3 Shinyamashita, Naka-ku, Yokohama 231, Japan. yn831522@city.yokohama.jp
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Noguchi
authors.forename: Yuji
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: Soichiro
authors.initials: S
authors.lastname: Morinaga
authors.forename: Tomishige
authors.initials: T
authors.lastname: Amano
authors.forename: Takaki
authors.initials: T
authors.lastname: Yoshikawa
authors.forename: Akira
authors.initials: A
authors.lastname: Tsuburaya
authors.forename: Osamu
authors.initials: O
authors.lastname: Kobayashi
authors.forename: Motonori
authors.initials: M
authors.lastname: Sairenji
authors.forename: Hisataka
authors.initials: H
authors.lastname: Motohashi
mesh_terms: D005743:Gastrectomy; D006801:Humans; D008207:Lymphatic Metastasis; D010180:Pancreatectomy; D011379:Prognosis; D012189:Retrospective Studies; D013156:Splenectomy; D013274:Stomach Neoplasms / Q000401:mortality* / Q000473:pathology / Q000601:surgery*; D016019:Survival Analysis